Growth Response in Girls With Turner Syndrome

• Status: Completed
• Trial end date: 2003-05-21
• Target enrollment: 0
• Participant gender: Female

Summary

This trial is conducted in Europe. The aim of the trial is to evaluate growth response of two somatropin dose regimens in girls with Turner Syndrome.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Novo Nordisk A/S

Criteria

Inclusion Criteria:

• Turner syndrome

• If age below 3 years, either body height below - 1 SD (standard deviation) with average growth velocity according to chronological age or body height below 0 SD with growth velocity below -1 SD according to chronological age

• If age above 3 years, body height below - 1 SD with average growth velocity according to chronological age

• Measured parental height available

• Written informed consent